KM

Kathriguppe Munikrishnappa Manohar

Active Director Director DIN 10582522
DIN 10582522 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kathriguppe Munikrishnappa Manohar

Data last updated:

Kathriguppe Munikrishnappa Manohar is a Director at Biophilin Pharmaceuticals Private Limited (since 2024) and Designated Partner at Globery Pharmaceuticals Llp (since 2024). The companies operate in Pharma.

DIN 10582522
Primary Designation Director
Industry Pharma
First Appointment 07 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20242024Active
Designated Partner07 Apr 20242024Active

Board colleagues of Kathriguppe Munikrishnappa Manohar

Directorship timeline

Open interactive timeline →
Biophilin Pharmaceuticals Private Limited
Globery Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Kathriguppe Munikrishnappa Manohar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kathriguppe Munikrishnappa Manohar

Kathriguppe Munikrishnappa Manohar currently holds 2 directorships: Biophilin Pharmaceuticals Private Limited (Director, since 28 May 2024); Globery Pharmaceuticals Llp (Designated Partner, since 07 Apr 2024).

Kathriguppe Munikrishnappa Manohar was first appointed on 07 Apr 2024 as Designated Partner at Globery Pharmaceuticals Llp.

The current boards of Kathriguppe Munikrishnappa Manohar's companies include Beemanna Murali (Biophilin Pharmaceuticals Private Limited), Sharathkumar Kasavanahalli Jagadeesh (Biophilin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available